|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| C07K 14/4711 | (2013.01) | ||
| C07K 16/18 | (2006.01) | ||
| C07K 16/18 | (2013.01) | ||
| C12N 15/02 | (2006.01) | ||
| A61P 25/28 | (2018.01) | ||
| C12P 21/08 | (2006.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Patento numeris | 3662931 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19207405.2 |
| Europos patento paraiškos padavimo data | 2013-05-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-06-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 2012124336 | 2012-05-31 | JP |
| (72) |
MORI, Hiroshi , JP
TOMIYAMA, Takami , JP
MATSUMOTO, Yoichi , JP
EGUCHI, Hiroshi , JP
KUNORI, Yuichi , JP
|
| (73) |
University Public Corporation Osaka ,
2-7-601, Asahimachi 1-chome
Abeno-ku, Osaka City 545-0051,
JP
Teijin Pharma Limited , 2-1, Kasumigaseki 3-chome Chiyoda-ku, Tokyo 100-0013, JP |
| (54) | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMENTIA |
| THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMENTIA |